Viral amyloids: New opportunities for antiviral therapeutic strategies - Archive ouverte HAL Access content directly
Journal Articles (Review Article) Current Opinion in Structural Biology Year : 2023

Viral amyloids: New opportunities for antiviral therapeutic strategies

Abstract

Amyloidoses are an array of diseases associated with the aggregation of proteins into fibrils. While it was previously thought that amyloid fibril-forming proteins are exclusively host-cell encoded, recent studies have revealed that pathogenic viruses can form amyloid-like fibrils too. Intriguingly, viral amyloids are often composed of virulence factors, known for their contribution to cell death and disease progression. In this review, we survey the literature about viral proteins capable of forming amyloidlike fibrils. The molecular and cellular mechanisms underlying the formation of viral amyloid-like aggregates are explored. In addition, we discuss the functional implications for viral amplification and the complex interplay between viral amyloids, biological functions, virulence, and virus-induced pathologies.
Embargoed file
Embargoed file
0 5 17
Year Month Jours
Avant la publication
Tuesday, October 1, 2024
Embargoed file
Tuesday, October 1, 2024
Please log in to request access to the document

Dates and versions

hal-04233136 , version 1 (09-10-2023)

Identifiers

Cite

Frank Gondelaud, Pierre-Yves Lozach, Sonia Longhi. Viral amyloids: New opportunities for antiviral therapeutic strategies. Current Opinion in Structural Biology, 2023, 83, pp.102706. ⟨10.1016/j.sbi.2023.102706⟩. ⟨hal-04233136⟩
18 View
1 Download

Altmetric

Share

Gmail Facebook X LinkedIn More